Inflammatory Bowel Disease Therapy Market, Global Outlook and Forecast 2022-2028

February 2022 | 66 pages | ID: IE2C8FFF3F1FEN
Market Monitor Global

Abstracts

Inflammatory bowel disease (IBD) is a chronic inflammatory bowel disease of unknown etiology, mainly including ulcerative colitis (UC) and crohn's disease (CD).The etiology may include environmental, infectious, immune and genetic factors.Because the etiology of inflammatory bowel disease is not clear, clinical symptoms are not specific, easy to be confused with other diseases, so the diagnosis is more difficult.Once misdiagnosis is caused by mistreatment, the result is mild but not cured, serious is life-threatening.The diagnosis of inflammatory bowel disease mainly includes the collection of clinical history, colonoscopy, imaging and mucosal histology.

This report contains market size and forecasts of Inflammatory Bowel Disease Therapy in Global, including the following market information:

Global Inflammatory Bowel Disease Therapy Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Inflammatory Bowel Disease Therapy market was valued at 17780 million in 2021 and is projected to reach US$ 22520 million by 2028, at a CAGR of 3.4% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Ulcerative Colitis Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Inflammatory Bowel Disease Therapy include Johnson & Johnson, AbbVie, Takeda Pharmaceutical Company, Abbott, Celgene Corporation, Innovate Biopharma, Cosmo Pharmaceuticals, Gilead Sciences and Pfizer. etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Inflammatory Bowel Disease Therapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Inflammatory Bowel Disease Therapy Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Inflammatory Bowel Disease Therapy Market Segment Percentages, by Type, 2021 (%)

• Ulcerative Colitis
• Crohns Disease
• Others

Global Inflammatory Bowel Disease Therapy Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Inflammatory Bowel Disease Therapy Market Segment Percentages, by Application, 2021 (%)

• Hospital
• Medical Research Organization
• Other

Global Inflammatory Bowel Disease Therapy Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Inflammatory Bowel Disease Therapy Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Inflammatory Bowel Disease Therapy revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Inflammatory Bowel Disease Therapy revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Johnson & Johnson
• AbbVie
• Takeda Pharmaceutical Company
• Abbott
• Celgene Corporation
• Innovate Biopharma
• Cosmo Pharmaceuticals
• Gilead Sciences
• Pfizer

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Inflammatory Bowel Disease Therapy Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Inflammatory Bowel Disease Therapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL INFLAMMATORY BOWEL DISEASE THERAPY OVERALL MARKET SIZE

2.1 Global Inflammatory Bowel Disease Therapy Market Size: 2021 VS 2028
2.2 Global Inflammatory Bowel Disease Therapy Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Inflammatory Bowel Disease Therapy Players in Global Market
3.2 Top Global Inflammatory Bowel Disease Therapy Companies Ranked by Revenue
3.3 Global Inflammatory Bowel Disease Therapy Revenue by Companies
3.4 Top 3 and Top 5 Inflammatory Bowel Disease Therapy Companies in Global Market, by Revenue in 2021
3.5 Global Companies Inflammatory Bowel Disease Therapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 Inflammatory Bowel Disease Therapy Players in Global Market
  3.6.1 List of Global Tier 1 Inflammatory Bowel Disease Therapy Companies
  3.6.2 List of Global Tier 2 and Tier 3 Inflammatory Bowel Disease Therapy Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Inflammatory Bowel Disease Therapy Market Size Markets, 2021 & 2028
  4.1.2 Ulcerative Colitis
  4.1.3 Crohns Disease
  4.1.4 Others
4.2 By Type - Global Inflammatory Bowel Disease Therapy Revenue & Forecasts
  4.2.1 By Type - Global Inflammatory Bowel Disease Therapy Revenue, 2017-2022
  4.2.2 By Type - Global Inflammatory Bowel Disease Therapy Revenue, 2023-2028
  4.2.3 By Type - Global Inflammatory Bowel Disease Therapy Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Inflammatory Bowel Disease Therapy Market Size, 2021 & 2028
  5.1.2 Hospital
  5.1.3 Medical Research Organization
  5.1.4 Other
5.2 By Application - Global Inflammatory Bowel Disease Therapy Revenue & Forecasts
  5.2.1 By Application - Global Inflammatory Bowel Disease Therapy Revenue, 2017-2022
  5.2.2 By Application - Global Inflammatory Bowel Disease Therapy Revenue, 2023-2028
  5.2.3 By Application - Global Inflammatory Bowel Disease Therapy Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Inflammatory Bowel Disease Therapy Market Size, 2021 & 2028
6.2 By Region - Global Inflammatory Bowel Disease Therapy Revenue & Forecasts
  6.2.1 By Region - Global Inflammatory Bowel Disease Therapy Revenue, 2017-2022
  6.2.2 By Region - Global Inflammatory Bowel Disease Therapy Revenue, 2023-2028
  6.2.3 By Region - Global Inflammatory Bowel Disease Therapy Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Inflammatory Bowel Disease Therapy Revenue, 2017-2028
  6.3.2 US Inflammatory Bowel Disease Therapy Market Size, 2017-2028
  6.3.3 Canada Inflammatory Bowel Disease Therapy Market Size, 2017-2028
  6.3.4 Mexico Inflammatory Bowel Disease Therapy Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Inflammatory Bowel Disease Therapy Revenue, 2017-2028
  6.4.2 Germany Inflammatory Bowel Disease Therapy Market Size, 2017-2028
  6.4.3 France Inflammatory Bowel Disease Therapy Market Size, 2017-2028
  6.4.4 U.K. Inflammatory Bowel Disease Therapy Market Size, 2017-2028
  6.4.5 Italy Inflammatory Bowel Disease Therapy Market Size, 2017-2028
  6.4.6 Russia Inflammatory Bowel Disease Therapy Market Size, 2017-2028
  6.4.7 Nordic Countries Inflammatory Bowel Disease Therapy Market Size, 2017-2028
  6.4.8 Benelux Inflammatory Bowel Disease Therapy Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Inflammatory Bowel Disease Therapy Revenue, 2017-2028
  6.5.2 China Inflammatory Bowel Disease Therapy Market Size, 2017-2028
  6.5.3 Japan Inflammatory Bowel Disease Therapy Market Size, 2017-2028
  6.5.4 South Korea Inflammatory Bowel Disease Therapy Market Size, 2017-2028
  6.5.5 Southeast Asia Inflammatory Bowel Disease Therapy Market Size, 2017-2028
  6.5.6 India Inflammatory Bowel Disease Therapy Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Inflammatory Bowel Disease Therapy Revenue, 2017-2028
  6.6.2 Brazil Inflammatory Bowel Disease Therapy Market Size, 2017-2028
  6.6.3 Argentina Inflammatory Bowel Disease Therapy Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Inflammatory Bowel Disease Therapy Revenue, 2017-2028
  6.7.2 Turkey Inflammatory Bowel Disease Therapy Market Size, 2017-2028
  6.7.3 Israel Inflammatory Bowel Disease Therapy Market Size, 2017-2028
  6.7.4 Saudi Arabia Inflammatory Bowel Disease Therapy Market Size, 2017-2028
  6.7.5 UAE Inflammatory Bowel Disease Therapy Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Johnson & Johnson
  7.1.1 Johnson & Johnson Corporate Summary
  7.1.2 Johnson & Johnson Business Overview
  7.1.3 Johnson & Johnson Inflammatory Bowel Disease Therapy Major Product Offerings
  7.1.4 Johnson & Johnson Inflammatory Bowel Disease Therapy Revenue in Global Market (2017-2022)
  7.1.5 Johnson & Johnson Key News
7.2 AbbVie
  7.2.1 AbbVie Corporate Summary
  7.2.2 AbbVie Business Overview
  7.2.3 AbbVie Inflammatory Bowel Disease Therapy Major Product Offerings
  7.2.4 AbbVie Inflammatory Bowel Disease Therapy Revenue in Global Market (2017-2022)
  7.2.5 AbbVie Key News
7.3 Takeda Pharmaceutical Company
  7.3.1 Takeda Pharmaceutical Company Corporate Summary
  7.3.2 Takeda Pharmaceutical Company Business Overview
  7.3.3 Takeda Pharmaceutical Company Inflammatory Bowel Disease Therapy Major Product Offerings
  7.3.4 Takeda Pharmaceutical Company Inflammatory Bowel Disease Therapy Revenue in Global Market (2017-2022)
  7.3.5 Takeda Pharmaceutical Company Key News
7.4 Abbott
  7.4.1 Abbott Corporate Summary
  7.4.2 Abbott Business Overview
  7.4.3 Abbott Inflammatory Bowel Disease Therapy Major Product Offerings
  7.4.4 Abbott Inflammatory Bowel Disease Therapy Revenue in Global Market (2017-2022)
  7.4.5 Abbott Key News
7.5 Celgene Corporation
  7.5.1 Celgene Corporation Corporate Summary
  7.5.2 Celgene Corporation Business Overview
  7.5.3 Celgene Corporation Inflammatory Bowel Disease Therapy Major Product Offerings
  7.5.4 Celgene Corporation Inflammatory Bowel Disease Therapy Revenue in Global Market (2017-2022)
  7.5.5 Celgene Corporation Key News
7.6 Innovate Biopharma
  7.6.1 Innovate Biopharma Corporate Summary
  7.6.2 Innovate Biopharma Business Overview
  7.6.3 Innovate Biopharma Inflammatory Bowel Disease Therapy Major Product Offerings
  7.6.4 Innovate Biopharma Inflammatory Bowel Disease Therapy Revenue in Global Market (2017-2022)
  7.6.5 Innovate Biopharma Key News
7.7 Cosmo Pharmaceuticals
  7.7.1 Cosmo Pharmaceuticals Corporate Summary
  7.7.2 Cosmo Pharmaceuticals Business Overview
  7.7.3 Cosmo Pharmaceuticals Inflammatory Bowel Disease Therapy Major Product Offerings
  7.7.4 Cosmo Pharmaceuticals Inflammatory Bowel Disease Therapy Revenue in Global Market (2017-2022)
  7.7.5 Cosmo Pharmaceuticals Key News
7.8 Gilead Sciences
  7.8.1 Gilead Sciences Corporate Summary
  7.8.2 Gilead Sciences Business Overview
  7.8.3 Gilead Sciences Inflammatory Bowel Disease Therapy Major Product Offerings
  7.8.4 Gilead Sciences Inflammatory Bowel Disease Therapy Revenue in Global Market (2017-2022)
  7.8.5 Gilead Sciences Key News
7.9 Pfizer
  7.9.1 Pfizer Corporate Summary
  7.9.2 Pfizer Business Overview
  7.9.3 Pfizer Inflammatory Bowel Disease Therapy Major Product Offerings
  7.9.4 Pfizer Inflammatory Bowel Disease Therapy Revenue in Global Market (2017-2022)
  7.9.5 Pfizer Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Inflammatory Bowel Disease Therapy Market Opportunities & Trends in Global Market
Table 2. Inflammatory Bowel Disease Therapy Market Drivers in Global Market
Table 3. Inflammatory Bowel Disease Therapy Market Restraints in Global Market
Table 4. Key Players of Inflammatory Bowel Disease Therapy in Global Market
Table 5. Top Inflammatory Bowel Disease Therapy Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Inflammatory Bowel Disease Therapy Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Inflammatory Bowel Disease Therapy Revenue Share by Companies, 2017-2022
Table 8. Global Companies Inflammatory Bowel Disease Therapy Product Type
Table 9. List of Global Tier 1 Inflammatory Bowel Disease Therapy Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Inflammatory Bowel Disease Therapy Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Inflammatory Bowel Disease Therapy Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Inflammatory Bowel Disease Therapy Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Inflammatory Bowel Disease Therapy Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Inflammatory Bowel Disease Therapy Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Inflammatory Bowel Disease Therapy Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Inflammatory Bowel Disease Therapy Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Inflammatory Bowel Disease Therapy Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Inflammatory Bowel Disease Therapy Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Inflammatory Bowel Disease Therapy Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Inflammatory Bowel Disease Therapy Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Inflammatory Bowel Disease Therapy Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Inflammatory Bowel Disease Therapy Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Inflammatory Bowel Disease Therapy Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Inflammatory Bowel Disease Therapy Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Inflammatory Bowel Disease Therapy Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Inflammatory Bowel Disease Therapy Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Inflammatory Bowel Disease Therapy Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Inflammatory Bowel Disease Therapy Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Inflammatory Bowel Disease Therapy Revenue, (US$, Mn), 2023-2028
Table 30. Johnson & Johnson Corporate Summary
Table 31. Johnson & Johnson Inflammatory Bowel Disease Therapy Product Offerings
Table 32. Johnson & Johnson Inflammatory Bowel Disease Therapy Revenue (US$, Mn), (2017-2022)
Table 33. AbbVie Corporate Summary
Table 34. AbbVie Inflammatory Bowel Disease Therapy Product Offerings
Table 35. AbbVie Inflammatory Bowel Disease Therapy Revenue (US$, Mn), (2017-2022)
Table 36. Takeda Pharmaceutical Company Corporate Summary
Table 37. Takeda Pharmaceutical Company Inflammatory Bowel Disease Therapy Product Offerings
Table 38. Takeda Pharmaceutical Company Inflammatory Bowel Disease Therapy Revenue (US$, Mn), (2017-2022)
Table 39. Abbott Corporate Summary
Table 40. Abbott Inflammatory Bowel Disease Therapy Product Offerings
Table 41. Abbott Inflammatory Bowel Disease Therapy Revenue (US$, Mn), (2017-2022)
Table 42. Celgene Corporation Corporate Summary
Table 43. Celgene Corporation Inflammatory Bowel Disease Therapy Product Offerings
Table 44. Celgene Corporation Inflammatory Bowel Disease Therapy Revenue (US$, Mn), (2017-2022)
Table 45. Innovate Biopharma Corporate Summary
Table 46. Innovate Biopharma Inflammatory Bowel Disease Therapy Product Offerings
Table 47. Innovate Biopharma Inflammatory Bowel Disease Therapy Revenue (US$, Mn), (2017-2022)
Table 48. Cosmo Pharmaceuticals Corporate Summary
Table 49. Cosmo Pharmaceuticals Inflammatory Bowel Disease Therapy Product Offerings
Table 50. Cosmo Pharmaceuticals Inflammatory Bowel Disease Therapy Revenue (US$, Mn), (2017-2022)
Table 51. Gilead Sciences Corporate Summary
Table 52. Gilead Sciences Inflammatory Bowel Disease Therapy Product Offerings
Table 53. Gilead Sciences Inflammatory Bowel Disease Therapy Revenue (US$, Mn), (2017-2022)
Table 54. Pfizer Corporate Summary
Table 55. Pfizer Inflammatory Bowel Disease Therapy Product Offerings
Table 56. Pfizer Inflammatory Bowel Disease Therapy Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Inflammatory Bowel Disease Therapy Segment by Type in 2021
Figure 2. Inflammatory Bowel Disease Therapy Segment by Application in 2021
Figure 3. Global Inflammatory Bowel Disease Therapy Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Inflammatory Bowel Disease Therapy Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Inflammatory Bowel Disease Therapy Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Inflammatory Bowel Disease Therapy Revenue in 2021
Figure 8. By Type - Global Inflammatory Bowel Disease Therapy Revenue Market Share, 2017-2028
Figure 9. By Application - Global Inflammatory Bowel Disease Therapy Revenue Market Share, 2017-2028
Figure 10. By Region - Global Inflammatory Bowel Disease Therapy Revenue Market Share, 2017-2028
Figure 11. By Country - North America Inflammatory Bowel Disease Therapy Revenue Market Share, 2017-2028
Figure 12. US Inflammatory Bowel Disease Therapy Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Inflammatory Bowel Disease Therapy Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Inflammatory Bowel Disease Therapy Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Inflammatory Bowel Disease Therapy Revenue Market Share, 2017-2028
Figure 16. Germany Inflammatory Bowel Disease Therapy Revenue, (US$, Mn), 2017-2028
Figure 17. France Inflammatory Bowel Disease Therapy Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Inflammatory Bowel Disease Therapy Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Inflammatory Bowel Disease Therapy Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Inflammatory Bowel Disease Therapy Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Inflammatory Bowel Disease Therapy Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Inflammatory Bowel Disease Therapy Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Inflammatory Bowel Disease Therapy Revenue Market Share, 2017-2028
Figure 24. China Inflammatory Bowel Disease Therapy Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Inflammatory Bowel Disease Therapy Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Inflammatory Bowel Disease Therapy Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Inflammatory Bowel Disease Therapy Revenue, (US$, Mn), 2017-2028
Figure 28. India Inflammatory Bowel Disease Therapy Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Inflammatory Bowel Disease Therapy Revenue Market Share, 2017-2028
Figure 30. Brazil Inflammatory Bowel Disease Therapy Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Inflammatory Bowel Disease Therapy Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Inflammatory Bowel Disease Therapy Revenue Market Share, 2017-2028
Figure 33. Turkey Inflammatory Bowel Disease Therapy Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Inflammatory Bowel Disease Therapy Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Inflammatory Bowel Disease Therapy Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Inflammatory Bowel Disease Therapy Revenue, (US$, Mn), 2017-2028
Figure 37. Johnson & Johnson Inflammatory Bowel Disease Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. AbbVie Inflammatory Bowel Disease Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Takeda Pharmaceutical Company Inflammatory Bowel Disease Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Abbott Inflammatory Bowel Disease Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Celgene Corporation Inflammatory Bowel Disease Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Innovate Biopharma Inflammatory Bowel Disease Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Cosmo Pharmaceuticals Inflammatory Bowel Disease Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Gilead Sciences Inflammatory Bowel Disease Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Pfizer Inflammatory Bowel Disease Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)